Pinckney, MI, United States of America

Richard Copp

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Richard Copp: Innovator in Pharmaceutical Chemistry

Introduction

Richard Copp is an accomplished inventor based in Pinckney, MI, USA, recognized for his contributions to pharmaceutical chemistry. With a remarkable portfolio of 7 patents, he has demonstrated a commitment to advancing medical treatments through innovative solutions.

Latest Patents

Copp's latest patents encompass groundbreaking methods related to bempedoic acid, showcasing his inventive prowess. The first patent outlines methods of making 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and the development of pharmaceutical materials containing this compound. These innovations aim to provide effective treatments for various diseases and conditions.

The second patent focuses on the crystalline salt and cocrystal forms of bempedoic acid, further emphasizing the versatility of this compound. It includes pharmaceutical materials that incorporate these forms, aiming to enhance treatment options for patients suffering from diverse health challenges.

Career Highlights

Copp is currently affiliated with Esperion Therapeutics, Inc., a company dedicated to discovering and developing innovative therapeutics for the treatment of cardiovascular disease. His role involves leveraging his expertise in chemistry to contribute to the company's cutting-edge research and development efforts.

Collaborations

Throughout his career, Richard Copp has collaborated with talented individuals such as Mohamed Abdelnasser and Christopher M. Cimarusti. These collaborations foster a rich environment for innovation, allowing for the exchange of ideas and the joint pursuit of breakthrough inventions.

Conclusion

Richard Copp stands out as a notable inventor in the field of pharmaceutical chemistry. His patented innovations not only reflect his skill and dedication but also hold significant potential for improving patient care through advanced therapeutic solutions. As he continues his work at Esperion Therapeutics, Inc., the medical community eagerly anticipates the far-reaching impacts of his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…